KR20120008370A - Anti-cancer composition comprising extract from hylocereus undatus - Google Patents
Anti-cancer composition comprising extract from hylocereus undatus Download PDFInfo
- Publication number
- KR20120008370A KR20120008370A KR1020100069185A KR20100069185A KR20120008370A KR 20120008370 A KR20120008370 A KR 20120008370A KR 1020100069185 A KR1020100069185 A KR 1020100069185A KR 20100069185 A KR20100069185 A KR 20100069185A KR 20120008370 A KR20120008370 A KR 20120008370A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- pitaya
- cancer
- composition
- activity
- Prior art date
Links
- 244000157072 Hylocereus undatus Species 0.000 title claims abstract description 86
- 239000000284 extract Substances 0.000 title claims abstract description 79
- 235000018481 Hylocereus undatus Nutrition 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 13
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 31
- 201000011510 cancer Diseases 0.000 claims abstract description 31
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims abstract description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000010837 Echinocereus enneacanthus subsp brevispinus Nutrition 0.000 claims description 56
- 235000006850 Echinocereus enneacanthus var dubius Nutrition 0.000 claims description 56
- 239000002904 solvent Substances 0.000 claims description 6
- 235000013376 functional food Nutrition 0.000 claims description 5
- 238000011282 treatment Methods 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 2
- 235000013305 food Nutrition 0.000 abstract description 7
- 230000009702 cancer cell proliferation Effects 0.000 abstract description 3
- 230000037396 body weight Effects 0.000 abstract description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 235000013824 polyphenols Nutrition 0.000 description 36
- 229930003935 flavonoid Natural products 0.000 description 32
- 235000017173 flavonoids Nutrition 0.000 description 32
- 150000002215 flavonoids Chemical class 0.000 description 30
- 150000008442 polyphenolic compounds Chemical class 0.000 description 30
- 230000002292 Radical scavenging effect Effects 0.000 description 28
- 230000003078 antioxidant effect Effects 0.000 description 23
- 230000001028 anti-proliverative effect Effects 0.000 description 18
- 235000013399 edible fruits Nutrition 0.000 description 15
- -1 flavonoid compound Chemical class 0.000 description 14
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 12
- 239000003963 antioxidant agent Substances 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 10
- 238000004435 EPR spectroscopy Methods 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 7
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 7
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 6
- 230000002000 scavenging effect Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 206010006187 Breast cancer Diseases 0.000 description 5
- 208000026310 Breast neoplasm Diseases 0.000 description 5
- 208000005718 Stomach Neoplasms Diseases 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 206010017758 gastric cancer Diseases 0.000 description 5
- 150000002989 phenols Chemical class 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 201000011549 stomach cancer Diseases 0.000 description 5
- VCUVETGKTILCLC-UHFFFAOYSA-N 5,5-dimethyl-1-pyrroline N-oxide Chemical compound CC1(C)CCC=[N+]1[O-] VCUVETGKTILCLC-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 206010008342 Cervix carcinoma Diseases 0.000 description 4
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 4
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 4
- 235000005487 catechin Nutrition 0.000 description 4
- 201000010881 cervical cancer Diseases 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 230000007760 free radical scavenging Effects 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 208000014829 head and neck neoplasm Diseases 0.000 description 4
- 239000000401 methanolic extract Substances 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 3
- LXEKPEMOWBOYRF-QDBORUFSSA-N AAPH Chemical compound Cl.Cl.NC(=N)C(C)(C)\N=N\C(C)(C)C(N)=N LXEKPEMOWBOYRF-QDBORUFSSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229950001002 cianidanol Drugs 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000002516 radical scavenger Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- WPBZMCGPFHZRHJ-UHFFFAOYSA-N 4-aminobenzohydrazide Chemical compound NNC(=O)C1=CC=C(N)C=C1 WPBZMCGPFHZRHJ-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003178 anti-diabetic effect Effects 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000007398 colorimetric assay Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 208000026037 malignant tumor of neck Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000010525 oxidative degradation reaction Methods 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QMYCJCOPYOPWTI-UHFFFAOYSA-N 2-[(1-amino-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidamide;hydron;chloride Chemical compound Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N QMYCJCOPYOPWTI-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010061424 Anal cancer Diseases 0.000 description 1
- 208000007860 Anus Neoplasms Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010005949 Bone cancer Diseases 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 240000005595 Echinocereus dasyacanthus Species 0.000 description 1
- 208000001976 Endocrine Gland Neoplasms Diseases 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 201000001342 Fallopian tube cancer Diseases 0.000 description 1
- 208000013452 Fallopian tube neoplasm Diseases 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000339701 Hylocereus costaricensis Species 0.000 description 1
- 241001190674 Hylocereus megalanthus Species 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 208000000821 Parathyroid Neoplasms Diseases 0.000 description 1
- 238000010220 Pearson correlation analysis Methods 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010068771 Soft tissue neoplasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 206010046431 Urethral cancer Diseases 0.000 description 1
- 206010046458 Urethral neoplasms Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 201000011165 anus cancer Diseases 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000000842 betacyanins Nutrition 0.000 description 1
- 235000016614 betalains Nutrition 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 201000006491 bone marrow cancer Diseases 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 229960001714 calcium phosphate Drugs 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 229960003340 calcium silicate Drugs 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003293 cardioprotective effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000009614 chemical analysis method Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 208000030381 cutaneous melanoma Diseases 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000001362 electron spin resonance spectrum Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 201000005787 hematologic cancer Diseases 0.000 description 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229960002163 hydrogen peroxide Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 201000010982 kidney cancer Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 208000029559 malignant endocrine neoplasm Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 208000026045 malignant tumor of parathyroid gland Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- SQDFHQJTAWCFIB-UHFFFAOYSA-N n-methylidenehydroxylamine Chemical compound ON=C SQDFHQJTAWCFIB-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 201000002575 ocular melanoma Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 125000000864 peroxy group Chemical group O(O*)* 0.000 description 1
- 239000002530 phenolic antioxidant Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 235000021013 raspberries Nutrition 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000003708 skin melanoma Diseases 0.000 description 1
- 201000002314 small intestine cancer Diseases 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 208000037965 uterine sarcoma Diseases 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Abstract
Description
본 발명은 백색 피타야(Hylocereus undatus) 추출물을 유효성분으로 포함하는 항암용 조성물에 관한 것이다.
The present invention relates to an anticancer composition comprising a white pitaya ( Hylocereus undatus ) extract as an active ingredient.
수요자들의 합성 항산화제 대한 염려는 천연의 항산화 물질에 대한 요구를 증대시켜왔다(Shahidi 1997). 식용 과실로부터의 과실 쥬스 및 펄프의 항산화 특성에 대한 다양한 연구결과가 보고되어 왔다(Mokbel and Hashinaga 2006). 과실은 자유 라디칼 소거에 중요한 역할을 하는 화합물이 풍부하기 때문에 이들의 항산화 활성은 주목받아 왔다. 사과(Wolfe and others 2003), 포도씨(Chidambara-Murthy and others 2002), 딸기(Meyers and others 2003), 일반 야채(Chu and others 2002), 및 라스베리(Liu and others 2002)에 관한 다양한 연구들에 의하면, 이들 과일 및 야채들은 항증식 효과를 갖는다고 보고되어 있다. 그러나, 식물 유래의 다른 식품의 항산화 및 항증식 활성은 잘 연구되어 있지 않고, 아열대 과일의 의약 및 영양학적 값에 대해서 얻을 수 있는 정보는 매우 제한되어 있다. Consumers' concerns about synthetic antioxidants have increased the need for natural antioxidants (Shahidi 1997). Various studies have been reported on the antioxidant properties of fruit juices and pulp from edible fruits (Mokbel and Hashinaga 2006). Fruits have been noted for their antioxidant activity because they are rich in compounds that play an important role in free radical scavenging. Various studies on apples (Wolfe and others 2003), grape seeds (Chidambara-Murthy and others 2002), strawberries (Meyers and others 2003), common vegetables (Chu and others 2002), and raspberries (Liu and others 2002) These fruits and vegetables are reported to have antiproliferative effects. However, the antioxidant and antiproliferative activities of other plant-derived foods are not well studied, and the information available on the medicinal and nutritional values of subtropical fruits is very limited.
피타야(Pitaya)는 아즈텍 종족에게서 매우 널리 알려진 과일이었다는 것이 역사 문서에 언급되어 있다. 멕시코와 중앙 아메리카 및 남미가 원산지인 이 과일은 서반구에서 오랫동안 소비되어 왔다(Mizrahi and others 1997). 현재 최근의 기후가 피타야의 재배에 적합하게 변화되고 있는 한국의 제주도에서도 재배되고 있다. 피타야의 껍질은 포엽(bract) 또는 비늘(scale)으로 덮여 있어 용과(dragon fruit)으로보 불리운다. 이들의 과피 및 펄프 색깔에 기초하여, 피타야는 백색 피타야(Hylocereus undatus), 적색 피타야(H. costaricensis) 및 노란색 피타야(Selenicereus megalanthus)로 분류되어 왔다(Nerd and others 2002, Hoa and others 2006). 피타야 과일은 식품으로서 매우 뛰어난 색깔과 경제적인 가치 이외에도 건강에 유익한 특성을 가졌다는 점 때문에 많은 관심을 끌고 있다(Chen and He 2007, Li and others 2003). 예를 들어, 적색 피타야는 베타시아닌 함유에 의해 부여되는 항산화 특성 뿐만 아니라 항암 효능, 항-염증 및 항-당뇨 효능과 심혈관 질환의 사망률 감소를 포함하여 매우 다양한 효능을 갖는 것으로 보고되었다(Cos and others 2004, Stintzing and others 2002; Wybranice and Mizrahi 2002). 백색 피타야 씨앗의 지방 오일은 심장-보호성, 항-당뇨 및 항균 특성을 갖는 리놀레산(linoleic acid)을 포함하는 것으로 알려져 있다(Das 2000, Szentmihㅱlyi 2002). 최근, 적색 및 백색 피타야의 과육 추출물로부터 폴리페놀과 플라보노이드의 함량을 측정한 보고가 있었으며, 적색 과육 추출물에 대해 DPPH (1,1-diphenyl-2-picrylhydrazyl) 자유 라디칼 소거 활성 및 HeLa 세포에 대한 항증식 활성을 측정한 결과가 보고되어 있다(Asmah and others, 2008). 또한, 적색 피타야는 B16F10 멜라노마 세포에 의해 유도되는 인간 구강암세포 전이 단계에서 세포독성효과를 보여주었다(Menon and others 1995). 또한, 피타야내의 베타레인(betalain)에 대한 화학적 연구 노력이 경주되고 있다(Wybranice and Mizrahi 2002, Stintzing and others 2004). 피타야의 건강상의 이점 및 이러한 이점을 부여하는 물질을 확인하려는 시도가 있지만, 피타야의 껍질 추출물에 대한 연구는 거이 이루어져 있지 않다.
It is mentioned in the historical documents that Pitaya was a very popular fruit from the Aztec race. Native to Mexico, Central and South America, this fruit has long been consumed in the Western Hemisphere (Mizrahi and others 1997). It is also grown on Jeju Island in Korea, where the current climate is changing to suit the cultivation of pitaya. The skin of a pitaya is covered with a bract or scale and is called a dragon fruit. Based on their skin and pulp color, pitaya has been classified as white pitaya (Hylocereus undatus), red pitaya (H. costaricensis) and yellow pitaya (Selenicereus megalanthus) (Nerd and others 2002, Hoa and others 2006). Pitaya fruit attracts a lot of attention because of its health benefits in addition to its excellent color and economic value as a food (Chen and He 2007, Li and others 2003). For example, red pitaya has been reported to have a wide variety of efficacy, including anticancer efficacy, anti-inflammatory and anti-diabetic efficacy, and reduced mortality of cardiovascular disease, as well as antioxidant properties conferred by beta cyanine content (Cos and others 2004, Stintzing and others 2002; Wybranice and Mizrahi 2002). Fatty oils of white pitaya seeds are known to contain linoleic acid with cardio-protective, anti-diabetic and antibacterial properties (Das 2000, Szentmihtmlyi 2002). Recently, there have been reports of polyphenol and flavonoid content from the flesh extracts of red and white pitaya, and the DPPH (1,1-diphenyl-2-picrylhydrazyl) free radical scavenging activity against HeLa cells The results of measuring antiproliferative activity have been reported (Asmah and others, 2008). In addition, red pitaya showed a cytotoxic effect at the stage of metastasis of human oral cancer cells induced by B16F10 melanoma cells (Menon and others 1995). In addition, chemical research efforts on betalain in pitaya are underway (Wybranice and Mizrahi 2002, Stintzing and others 2004). Attempts have been made to identify the health benefits of pitaya and the substances contributing these benefits, but little research has been done on pitaya's bark extracts.
본 명세서 전체에 걸쳐 다수의 논문 및 특허문헌이 참조되고 그 인용이 표시되어 있다. 인용된 논문 및 특허문헌의 개시 내용은 그 전체로서 본 명세서에 참조로 삽입되어 본 발명이 속하는 기술 분야의 수준 및 본 발명의 내용이 보다 명확하게 설명된다.
Numerous papers and patent documents are referenced and cited throughout this specification. The disclosures of cited papers and patent documents are incorporated herein by reference in their entirety, and the level of the technical field to which the present invention belongs and the contents of the present invention are more clearly explained.
본 발명자들은 천연물 원천으로부터 항산화 및 항증식 물질을 개발하기 위한 연구의 일환으로써 아열대성 과일인 피타야(Pitaya)의 추출물의 항산화활성 및 항암활성을 분석하였다. 그 결과, 피타야 추출물에 페놀성 화합물 및 플라보노이드 화합물이 매우 풍부하게 포함되어 있어 다양한 종류의 자유 라디칼에 대한 항산화 활성이 뛰어나며, 암세포주의 증식을 효과적으로 억제함을 확인하여 본 발명을 완성하였다.
The present inventors analyzed the antioxidant and anticancer activity of extracts of the subtropical fruit, Pitaya, as part of research to develop antioxidant and antiproliferative substances from natural sources. As a result, the phytic extract and the flavonoid compound contained very rich in phytaya extract, excellent in antioxidant activity against various kinds of free radicals, and effectively inhibited the proliferation of cancer cell lines to complete the present invention.
따라서, 본 발명의 목적은 백색 피타야(Hylocereus undatus) 추출물을 유효성분으로 포함하는 항암용 조성물을 제공하는 것에 있다.
Therefore, an object of the present invention is to provide an anticancer composition comprising a white pitaya ( Hylocereus undatus ) extract as an active ingredient.
본 발명의 목적 및 장점은 하기의 발명의 상세한 설명, 청구의 범위 및 도면에 의해 보다 명확하게 된다.
The objects and advantages of the invention will become apparent from the following detailed description, claims and drawings.
본 발명의 일 양태에 따르면, 본 발명은 백색 피타야 (Hylocereus undatus) 추출물을 유효성분으로 포함하는 항암용 조성물을 제공한다. According to one aspect of the invention, the present invention provides a composition for anticancer comprising a white pitaya ( Hylocereus undatus ) extract as an active ingredient.
본 발명의 바람직한 구현예에 의하면, 상기 백색 피타야 추출물은 백색 피타야의 껍질 또는 과육으로부터의 추출물이다. According to a preferred embodiment of the present invention, the white pitaya extract is an extract from the skin or flesh of the white pitaya.
본 발명에서 백색 피타야 추출물은 천연물로부터 추출물을 추출하는 당업계에 공지된 통상적인 방법에 따라, 즉, 통상적인 온도, 압력의 조건 하에서 통상적인 용매를 사용하여 분리할 수 있다. 본 발명의 백색 피타야 추출물을 추출하기 위한 추출 용매로는 추출공정에서 일반적으로 사용할 수 있는 용매를 사용할 수 있는데, 예를 들어 물, 탄소수 1-4개의 무수 또는 함수 저급 알코올, 아세톤, 에틸아세테이트, 부틸아세테이트 및 1,3-부틸렌 글리콜로 구성된 군으로부터 선택되는 용매를 사용하여 추출하는 것이 바람직하다. The white pitaya extract in the present invention can be separated according to conventional methods known in the art for extracting extracts from natural products, that is, using conventional solvents under the conditions of conventional temperature, pressure. As an extraction solvent for extracting the white pitaya extract of the present invention, a solvent that can be generally used in the extraction process may be used. For example, water, anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms, acetone, ethyl acetate, Preference is given to using a solvent selected from the group consisting of butyl acetate and 1,3-butylene glycol.
본 발명의 보다 바람직한 구현예에 의하면, 본 발명의 백색 피타야 추출물은 탄소수 1-4개의 무수 또는 함수 저급 알코올을 용매로 사용한 추출물이다.According to a more preferred embodiment of the present invention, the white pitaya extract of the present invention is an extract using anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms as a solvent.
본 발명의 유효성분 백색 피타야 (Hylocereus undatus) 추출물은 폴리페놀성 화합물과 플라보노이드 화합물을 포함하고 있으며, 다양한 종류의 암세포에 대해 암세포 증식 억제 활성을 갖는다. The active ingredient white pitaya ( Hylocereus undatus ) extract of the present invention contains a polyphenolic compound and a flavonoid compound, and has cancer cell proliferation inhibitory activity against various kinds of cancer cells.
본 발명의 바람직한 구현예에 의하면, 본 발명의 조성물은 암의 치료 또는 예방 용도의 약제학적 조성물의 형태로 제조될 수 있다. According to a preferred embodiment of the present invention, the composition of the present invention may be prepared in the form of a pharmaceutical composition for the treatment or prophylaxis of cancer.
본 발명의 다른 바람직한 구현예에 의하면, 본 발명에서의 치료 대상 암은 특정 암으로 한정되지 않으며, 예를 들어 유방암, 폐암, 위암, 간암, 혈액암, 뼈암, 췌장암, 피부암, 머리 또는 목암(head or neck cancer), 피부 또는 안구 흑색종, 자궁육종, 난소암, 직장암, 항문암, 대장암, 난관암, 자궁내막암, 자궁경부암, 소장암, 내분비암, 갑상선암, 부갑상선암, 신장암, 연조직종양, 요도암, 전립선암, 기관지암 또는 골수암을 들 수 있으며, 보다 바람직하게는 위암, 유방암 또는 자궁경부암이다. According to another preferred embodiment of the invention, the cancer to be treated in the present invention is not limited to a specific cancer, for example breast cancer, lung cancer, stomach cancer, liver cancer, blood cancer, bone cancer, pancreatic cancer, skin cancer, head or neck cancer (head or neck cancer), skin or eye melanoma, uterine sarcoma, ovarian cancer, rectal cancer, anal cancer, colon cancer, fallopian tube cancer, endometrial cancer, cervical cancer, small intestine cancer, endocrine cancer, thyroid cancer, parathyroid cancer, kidney cancer, soft tissue Tumors, urethral cancer, prostate cancer, bronchial cancer or bone marrow cancer, and more preferably gastric cancer, breast cancer or cervical cancer.
본 발명의 약제학적 조성물에는 유효성분으로서 백색 피타야 추출물 이외에 약제학적으로 허용되는 담체를 포함한다. The pharmaceutical composition of the present invention includes a pharmaceutically acceptable carrier in addition to the white pitaya extract as an active ingredient.
본 발명의 약제학적 조성물에 포함되는 약제학적으로 허용되는 담체는 제제시에 통상적으로 이용되는 것으로서, 락토스, 덱스트로스, 수크로스, 솔비톨, 만니톨, 전분, 아카시아 고무, 인산 칼슘, 알기네이트, 젤라틴, 규산 칼슘, 미세결정성 셀룰로스, 폴리비닐피롤리돈, 셀룰로스, 물, 시럽, 메틸 셀룰로스, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 활석, 스테아르산 마그네슘 및 미네랄 오일 등을 포함하나, 이에 한정되는 것은 아니다. Pharmaceutically acceptable carriers included in the pharmaceutical compositions of the present invention are those commonly used in the preparation, such as lactose, dextrose, sucrose, sorbitol, mannitol, starch, acacia rubber, calcium phosphate, alginate, gelatin, Calcium silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil, and the like It doesn't happen.
본 발명의 약제학적 조성물은 상기 성분들 이외에 윤활제, 습윤제, 감미제, 향미제, 유화제, 현탁제, 보존제 등을 추가로 포함할 수 있다. 적합한 약제학적으로 허용되는 담체 및 제제는 Remington's Pharmaceutical Sciences (19th ed., 1995)에 상세히 기재되어 있다. In addition to the above components, the pharmaceutical composition of the present invention may further include a lubricant, a humectant, a sweetener, a flavoring agent, an emulsifier, a suspending agent, a preservative, and the like. Suitable pharmaceutically acceptable carriers and formulations are described in detail in Remington's Pharmaceutical Sciences (19th ed., 1995).
본 발명의 약제학적 조성물의 적합한 투여량은 제제화 방법, 투여 방식, 환자의 연령, 체중, 성, 병적 상태, 음식, 투여 시간, 투여 경로, 배설 속도 및 반응 감응성과 같은 요인들에 의해 다양하게 처방될 수 있다. 한편, 본 발명의 약제학적 조성물의 경구 투여량은 바람직하게는 1일 당 0.001-1000 mg/kg(체중)이다. Suitable dosages of the pharmaceutical compositions of the present invention may vary depending on factors such as the formulation method, mode of administration, age, weight, sex, morbidity, condition of food, time of administration, route of administration, rate of excretion and response to response of the patient. Can be. On the other hand, the oral dosage of the pharmaceutical composition of the present invention is preferably 0.001-1000 mg / kg (body weight) per day.
본 발명의 약제학적 조성물은 경구 또는 비경구로 투여할 수 있고, 비경구로 투여되는 경우, 피부에 국소적으로 도포, 정맥내 주입, 피하 주입, 근육 주입, 복강 주입, 경피 투여 등으로 투여할 수 있다. The pharmaceutical composition of the present invention may be administered orally or parenterally, and when administered parenterally, may be administered topically to the skin, intravenous injection, subcutaneous injection, intramuscular injection, intraperitoneal injection, transdermal administration, and the like. .
본 발명의 조성물에 포함되는 유효성분인 백색 피타야 추출물의 농도는 치료 목적, 환자의 상태, 필요기간 등을 고려하여 결정할 수 있으며 특정 범위의 농도로 한정되지 않는다. The concentration of the white pitaya extract, which is an active ingredient included in the composition of the present invention, may be determined in consideration of the purpose of treatment, the condition of the patient, the period of time, etc., and is not limited to a specific range of concentration.
본 발명의 약제학적 조성물은 당해 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있는 방법에 따라, 약제학적으로 허용되는 담체 및/또는 부형제를 이용하여 제제화 함으로써 단위 용량 형태로 제조되거나 또는 다용량 용기내에 내입시켜 제조될 수 있다. 이때 제형은 오일 또는 수성 매질중의 용액, 현탁액 또는 유화액 형태이거나 엑스제, 분말제, 과립제, 정제 또는 캅셀제 형태일 수도 있으며, 분산제 또는 안정화제를 추가적으로 포함할 수 있다. The pharmaceutical composition of the present invention may be formulated into a unit dose form by formulating it using a pharmaceutically acceptable carrier and / or excipient according to a method which can be easily carried out by a person having ordinary skill in the art to which the present invention belongs. Or by intrusion into a multi-dose container. The formulations may be in the form of solutions, suspensions or emulsions in oils or aqueous media, or in the form of excipients, powders, granules, tablets or capsules, and may additionally contain dispersing or stabilizing agents.
본 발명의 다른 바람직한 구현예에 의하면, 본 발명의 조성물은 암의 완화 또는 개선 용도의 기능성 식품 조성물의 형태로 제조될 수 있다. According to another preferred embodiment of the present invention, the composition of the present invention may be prepared in the form of a functional food composition for use in alleviating or ameliorating cancer.
본 발명의 기능성 식품 조성물은 식품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분으로서 백색 피타야 추출물 이외에 향미제 또는 천연 탄수화물을 추가 성분으로서 포함시킬 수 있다. 예를 들어, 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등); 디사카라이드(예컨대, 말토스, 수크로오스 등); 올리고당; 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등); 및 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)을 포함한다. 향미제로서 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등) 및 합성 향미제(예컨대, 사카린, 아스파르탐 등)을 이용할 수 있다. Functional food compositions of the present invention include ingredients that are commonly added in the manufacture of food, and include, for example, proteins, carbohydrates, fats, nutrients and seasonings. For example, when prepared with a drink, it may be included as an additional ingredient a flavor or natural carbohydrate in addition to the white pitaya extract as an active ingredient. For example, natural carbohydrates include monosaccharides (eg, glucose, fructose, etc.); Disaccharides (eg maltose, sucrose, etc.); oligosaccharide; Polysaccharides (eg, dextrins, cyclodextrins, etc.); And sugar alcohols (eg, xylitol, sorbitol, erythritol, and the like). As the flavoring agent, natural flavoring agents (e.g., taumartin, stevia extract, etc.) and synthetic flavoring agents (e.g., saccharin, aspartame, etc.) can be used.
본 발명의 특징 및 이점을 요약하면 다음과 같다: The features and advantages of the present invention are summarized as follows:
(i) 본 발명은 백색 피타야 (Hylocereus undatus) 추출물의 신규한 항암 용도에 관한 것이다. (i) The present invention relates to a novel anticancer use of white pitaya ( Hylocereus undatus ) extract.
(ⅱ) 본 발명의 백색 피타야 (Hylocereus undatus) 추출물은 암세포의 증식을 억제하는 효능을 갖는다. (Ii) The white pitaya extract of the present invention ( Hylocereus undatus ) has the effect of inhibiting the proliferation of cancer cells.
(ⅲ) 본 발명의 백색 피타야 (Hylocereus undatus) 추출물은 암의 치료, 예방 또는 개선 용도의 약제학적 조성물 또는 기능성 식품 조성물로 개발될 수 있다.
(Iii) The white phytaya ( Hylocereus undatus ) extract of the present invention can be developed into a pharmaceutical composition or a functional food composition for use in the treatment, prevention or amelioration of cancer.
본 발명은 백색 피타야 (Hylocereus undatus) 추출물의 신규한 항암 용도에 관한 것이다. 본 발명의 백색 피타야 (Hylocereus undatus) 추출물은 암세포의 증식을 억제하는 항암효능을 갖는다. 본 발명의 백색 피타야 (Hylocereus undatus) 추출물은 암의 치료, 예방 또는 개선 용도의 약제학적 조성물 또는 기능성 식품 조성물로 개발될 수 있다.
The present invention relates to a novel anticancer use of white pitaya ( Hylocereus undatus ) extract. White pitaya extract of the present invention ( Hylocereus undatus ) has an anticancer effect of inhibiting the proliferation of cancer cells. The white pitaya ( Hylocereus undatus ) extract of the present invention can be developed into a pharmaceutical composition or a functional food composition for use in the treatment, prevention or amelioration of cancer.
도 1a 내지 도 1c는 백색 및 적색 피타야의 과육 및 껍질 추출물의 폴리페놀 및 플라보노이드 함량과 자유 라디칼 소거 활성과의 상관관계에 관한 결과를 보여준다.
도 1a는 히드록시 라디칼 소거 활성(%) vs. 폴리페놀 및 플라보노이드 함량과의 관계를 보여준다.
도 1b는 알킬 라디칼 소거 활성(%) vs. 폴리페놀 및 플라보노이드 함량과의 관계를 보여준다.
도 1c는 DPPH 라디칼 소거 활성(%) vs. 폴리페놀 및 플라보노이드 함량과의 관계를 보여준다.
도 2는 여러 가지 암세포주의 세포 생존능과 백색 및 적색 피타야 과육 및 껍질 추출물의 DPPH 라디칼 소거 활성과의 상관관계를 보여준다. 1A-1C show the results of the correlation between the polyphenol and flavonoid content and free radical scavenging activity of the pulp and bark extracts of white and red pitaya.
1A shows hydroxy radical scavenging activity (%) vs. The relationship with polyphenol and flavonoid content is shown.
Figure 1b shows alkyl radical scavenging activity (%) vs. The relationship with polyphenol and flavonoid content is shown.
Figure 1C shows DPPH radical scavenging activity (%) vs. The relationship with polyphenol and flavonoid content is shown.
Figure 2 shows the correlation between the cell viability of various cancer cell lines and DPPH radical scavenging activity of the white and red pitaya pulp and bark extract.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다.
Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention in more detail, it will be apparent to those skilled in the art that the scope of the present invention is not limited by these examples in accordance with the gist of the present invention. .
실시예 Example
실험 재료 및 방법 Materials and Methods
1. 화합물 1. Compound
Folin-Ciocalteu 페놀시약, 루틴(rutin), 갈산(gallic acid), 과산화수소(hydrogen peroxide), 황산제1철 (ferrous sulfate), DPPH, DMPO(5,5-dimethyl-1-pyrroline-N-oxide), AAPH[ [2,2'-azobis(2-amidinopropane)hydrochloride], 및 4-POBN[α-(4-pyridyl-1-oxide)-N-t-butylnitrone]은 Sigma Chemical Co. (St. Louis, MO, USA)으로부터 구입하였다. DMSO (Dimethyl sulfoxide) 및 MTT[3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]은 Amresco Inc. (Solon, OH, USA)으로부터 구입하였다. RPMI 1640 배지, DMEM (Dulbecco's modified Eagle's medium), 트립신/EDTA, FBS(fetal bovine serum), 페니실린 및 스트렙토마이신은 Invitrogen Inc. (Grand Island, NY, USA)으로부터 구입하였다. 다른 모든 화합물들과 시약은 분석용 등급의 것을 사용하였다.
Folin-Ciocalteu Phenolic Reagent, Rutin, Gallic Acid, Hydrogen Peroxide, Ferrous Sulfate, DPPH, DMPO (5,5-dimethyl-1-pyrroline-N-oxide) , AAPH [[2,2'-azobis (2-amidinopropane) hydrochloride], and 4-POBN [α- (4-pyridyl-1-oxide) -Nt-butylnitrone] are described in Sigma Chemical Co. (St. Louis, MO, USA). Dimethyl sulfoxide (DMSO) and MTT [3- (4, 5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide] are available from Amresco Inc. (Solon, OH, USA). RPMI 1640 medium, DMEM (Dulbecco's modified Eagle's medium), trypsin / EDTA, fetal bovine serum (FBS), penicillin and streptomycin are described by Invitrogen Inc. (Grand Island, NY, USA). All other compounds and reagents were of analytical grade.
2. 과일 2. Fruit
백색 및 적석 피타야(pitaya) 과일은 제주도의 한림공원 근처 농장에서 수집하였다. 모든 과일들을 세척하고 껍질을 조심스럽게 제거하였다. 과육 및 껍질을 작고 얇은 조각으로 자르고, 분석 실험에 사용하기 전까지 -70℃에서 보관하였다.
White and red pitaya fruits were collected on farms near Hallim Park in Jeju Island. All fruits were washed and the skin was carefully removed. The pulp and shells were cut into small thin slices and stored at −70 ° C. until used in the assay.
3. 샘플 준비 3. Sample preparation
과육 및 껍질 샘플들을 2일간 감압하에 동결건조하고 이어서 분말화하였다. 80% 메탄올에서의 추출은 소니케이션(sonication)과 함께 3일간 상온에서 수행하였다. 생성된 추출물을 Whatman No. 1 필터 페이퍼를 통해 여과시키고 40℃ 감압 로터리 증발기를 사용하여 농축시킨 후에 동결건조하였다. 이들을 DMSO 내에서 용해시키고 PBS(phosphate-buffered saline, pH 7.4)내에서 희석하여 최종 사용 농도로 제조하였다. 각 식물체로부터 얻은 메탄올 추출물에 대해 페놀 화합물 총함량, DPPH 라디칼 소거 활성 및 세포독성을 측정하였다.
The pulp and skin samples were lyophilized under reduced pressure for 2 days and then powdered. Extraction in 80% methanol was performed at room temperature for 3 days with sonication. The resulting extract was Whatman No. It was filtered through 1 filter paper and concentrated using a 40 ° C. reduced pressure rotary evaporator and then lyophilized. They were dissolved in DMSO and diluted in PBS (phosphate-buffered saline, pH 7.4) to prepare to final use concentrations. Methanol extracts from each plant were measured for total phenolic compound content, DPPH radical scavenging activity and cytotoxicity.
4. 총 폴리페놀 및 플라보노이드 수준의 측정 4. Determination of Total Polyphenols and Flavonoid Levels
총 폴리페놀 및 플라보노이드 수준은 약간의 수정을 가한 Cheung 방법(Cheung and others 2003)에 따라 측정하였다. 샘플 부분 표본(1.5㎖)을 0.5 ㎖의 Folin-Ciocalteu 페놀 시약과 혼합하였다. 5분 후에, 1 ㎖의 10% (w/v) Na2CO3를 각 반응 혼합액에 첨가하였다. 반응은 암조건에서 30분간 수행하였고, 725nm 에서의 흡광도는 UV 1800 분광계(Shimadzu, Tokyo, Japan)를 사용하여 기록하였다. 결과는 갈산 당량(gallic acid equivalent, GAE)(건조된 샘플의 mg GAE/g)으로 표시하였다. 플라보노이드 함량은 공지된 비색분석법(colorimetric assay)을 사용하여 측정하였다(Zhishen and others 1999). 흡광도는 블랭크(PBS)에 대해 510 nm에서 측정하고, 플라보노이드 함량은 루틴 당량(rutin equivalents, RE)(건조된 샘플의 mg RE/g)으로 표시하였다. 모든 분석은 적어도 3회 수행하였다.
Total polyphenol and flavonoid levels were measured according to the Cheung method (Cheung and others 2003) with minor modifications. Sample aliquots (1.5 mL) were mixed with 0.5 mL of Folin-Ciocalteu phenolic reagent. After 5 minutes, 1 ml of 10% (w / v) Na 2 CO 3 was added to each reaction mixture. The reaction was carried out under dark conditions for 30 minutes, and the absorbance at 725 nm was recorded using a UV 1800 spectrometer (Shimadzu, Tokyo, Japan). Results are expressed as gallic acid equivalent (GAE) (mg GAE / g of dried sample). Flavonoid content was measured using known colorimetric assays (Zhishen and others 1999). Absorbance was measured at 510 nm for blank (PBS) and flavonoid content was expressed in rutin equivalents (RE) (mg RE / g of dried sample). All analyzes were performed at least three times.
5. 5. DPPHDPPH 라디칼Radical 소거능Scatters ( ( DPPHDPPH radicalradical scavengingscavenging ) )
DPPH 라디칼 소거능은 이미 기술된 방법에 따라 측정하였다(Nanjo and others 1996). PBS 내에서 희석한 각 샘플의 30 μl 부분 표본 (또는 대조군으로서 PBS 단독)을 에탄올내의 30 μL DPPH (60 μM)에 추가하였다. 각각의 피타야 추출물의 최종 농도는 25 μg/㎖이었다. 10 초간 심하게 혼합한 후, 용액을 50 μL의 테프론 캐필러리 튜브안에 넣고, JES-FA 전자 스핀 공명(ESR, electron spin resonance) 분광기(JEOL, Tokyo, Japan)안으로 삽입하였다. 이어서 스핀 부가생성물을 2 분에 측정하였다. 측정 조건은 다음과 같았다: 중앙 필드 3475 G, 조절 진동수 100 kHz, 조절 진폭 2G, 마이크로웨이브 전력 5 mW, 게인(gain) 6.3 X 105 및 온도 297 K. 피타야 추출물의 라디칼 소거능은 다음의 공식에 따라 계산하였다: 소거 속도(scavenging rate) = (h0-hx)/h0 X 100%, 여기에서 h0 및 hx는 각각 추출물을 포함하고 있는 샘플 또는 포함하지 않는 샘플의 ESR 시그널 강도이다.
DPPH radical scavenging activity was determined according to the methods previously described (Nanjo and others 1996). 30 μl aliquots (or PBS alone as controls) of each sample diluted in PBS were added to 30 μL DPPH (60 μM) in ethanol. The final concentration of each pitaya extract was 25 μg / ml. After vigorous mixing for 10 seconds, the solution was placed in 50 μL of Teflon capillary tube and inserted into a JES-FA electron spin resonance (ESR) spectrometer (JEOL, Tokyo, Japan). The spin adduct was then measured at 2 minutes. The measurement conditions were as follows: center field 3475 G,
6. 히드록실 라디칼 소거능 6. hydroxyl radical scavenging ability
히드록실 라디칼(hydroxyl radical)은 펜톤 반응(Fenton reaction)에 의해 생성되고 니트론 스핀 트랩(nitrone spin trap) DMPO 와 빠르게 반응하였다. 생성된 DMPO-OH 반응부가물은 ESR에 의해 측정하였다(Rosen and Rauckman 1984). ESR 스펙트럼은 20 μL의 0.3 M DMPO, 20 μL의 10 mM FeSO4 및 20 μL의 10 mM H2O2를 첨가한 포스페이트 완충용액(pH 7.4)으로 혼합한 후 2.5 분에 다음의 조건하에서 측정하였다: 중앙 필드 3475 G, 조절 진동수 100 kHz, 조절 진폭 2 G, 마이크로 웨이브 전력 1 mW, 게인(gain) 6.3 X 105 및 온도 298 K. 각 피타야(pitaya) 추출물의 최종 농도는 2 mg/㎖ 이었다. 피타야 추출물의 라디칼 소거능은 다음의 공식에 따라 계산하였다: 소거 속도(scavenging rate) = (h0-hx)/h0 X 100%, 여기에서 h0 및 hx는 각각 추출물을 포함한 샘플과 추출물을 포함하지 않은 샘플의 ESR 시그널 강도이다.
The hydroxyl radical was produced by the Fenton reaction and reacted rapidly with the nitrone spin trap DMPO. The resulting DMPO-OH reaction adduct was measured by ESR (Rosen and Rauckman 1984). ESR spectra were measured in 2.5 minutes after mixing with 20 μL of 0.3 M DMPO, 20 μL of 10 mM FeSO 4 and 20 μL of 10 mM H 2 O 2 in phosphate buffer (pH 7.4) under the following conditions: : Center field 3475 G,
7. 알킬 라디칼 소거능 7. Alkyl radical scavenging ability
알킬 라디칼은 AAPH에 의해 생성되었다. 40 mM AAPH, 40 mM 4-POBN 및 PBS (pH 7.4)으로 희석하여 지시된 농도로 제조한 테스트 샘플을 함유하는 반응 혼합물을 37℃의 수조에서 30 분간 인큐베이션하고(Hiramoto and others 1993), 테프론 캐필러리 튜브에 넣었다. 각 피타야 추출물의 최종 농도는 200 μg/mL이었다. 스핀 부가 생성물은 ESR 분광기를 사용하여 기록하였다. 다음의 측정 조건을 사용하였다: 중앙 필드 3475 G, 조절 진동수 100 kHz, 조절 진폭 2 G, 마이크로웨이브 전력 10 mW, 게인(gain) 6.3 X 105, 및 온도 298 K. 피타야 추출물의 라디칼 소거능은 다음의 공식에 따라 계산하였다: 소거 속도(scavenging rate) = (h0-hx)/h0 X 100%, 여기에서 h0 및 hx는 각각 추출물을 포함한 샘플과 추출물을 포함하지 않은 샘플의 ESR 시그널 강도이다.
Alkyl radicals were produced by AAPH. The reaction mixture containing test samples prepared at the indicated concentrations diluted with 40 mM AAPH, 40 mM 4-POBN and PBS (pH 7.4) was incubated for 30 minutes in a 37 ° C. water bath (Hiramoto and others 1993) and Teflon Carb Placed in a filler tube. The final concentration of each pitaya extract was 200 μg / mL. Spin addition products were recorded using an ESR spectrometer. The following measurement conditions were used: center field 3475 G,
8. 세포의 배양 8. Culture of Cells
암세포주 AGS (인간 위암 세포주), HeLa (인간 자궁경부암 세포주), 및 MCF-7 (인간 유방암 세포주)는 한국 세포주은행(KCLB, Seoul, Korea)으로부터 얻었다. 이들 세포주들을 10%(v/v) 열-불활성화 FBS (fetal bovine serum), 100 units/㎖의 페니실린, 및 100 μg/㎖의 스트렙토마이신이 첨가된 DMEM 또는 RPMI 1640 배지를 이용하여 습화된 인큐베이터내에서 37℃, 5% CO2 분위기하에서 배양하였다.
Cancer cell lines AGS (human gastric cancer cell line), HeLa (human cervical cancer cell line), and MCF-7 (human breast cancer cell line) were obtained from the Korea Cell Line Bank (KCLB, Seoul, Korea). These cell lines were incubated with DMEM or RPMI 1640 medium supplemented with 10% (v / v) heat-inactivated fetal bovine serum (FBS), 100 units / ml penicillin, and 100 μg / ml streptomycin. Incubated in a 37 ° C., 5% CO 2 atmosphere.
9. 암세포의 생존능 분석 9. Viability Analysis of Cancer Cells
피타야 추출물의 다양한 암세포주읨 생존능에 대한 영향은 MTT 비색 분석법에 의해 측정하였다(Hansen and others 1989). 간략하게 설명하면, 대수기에 있는 암세포를 96-웰 플레이트(웰 당 2 X 103 내지 1 X 104 세포)에 분주하였다. 추출물의 다양한 농도(125 내지 1000 μg/mL) 또는 표준 물질(케르세틴(quercetin); 12.5 내지 200 μM/mL)의 존재하에서 72 시간 동안 인큐베이션하였다. 0.1 mg 의 MTT를 각 웰에 추가하고 세포들을 37℃에서 4 시간 동안 인큐베이션하였다. 이어서, 성장 배지를 조심스럽게 제거하였고, 형성된 포르마잔 결정을 용해시키기 위해 DMSO(150 μl)를 각 웰에 첨가하였다. 570 nm에서의 흡광도는 마이크로플레이트 리더 (Tecan, Salzburg, Austria)를 사용하여 즉시 기록하였다. 세포 생존능은 처리하지 않은 대조군 세포에 대해 백분율로서 표시하였다.
The effect of pitaya extract on the viability of various cancer cell lines was measured by MTT colorimetric assay (Hansen and others 1989). Briefly, cancer cells in log phase were dispensed into 96-well plates (2 × 10 3 to 1 × 10 4 cells per well). Incubated for 72 hours in the presence of various concentrations of extract (125-1000 μg / mL) or standard material (quercetin; 12.5-200 μM / mL). 0.1 mg of MTT was added to each well and the cells were incubated at 37 ° C. for 4 hours. The growth medium was then carefully removed and DMSO (150 μl) was added to each well to dissolve the formazan crystals formed. Absorbance at 570 nm was recorded immediately using a microplate reader (Tecan, Salzburg, Austria). Cell viability is expressed as a percentage of untreated control cells.
10. 생-활성 인덱스(bioactivity index) 측정 10. Determination of the bioactivity index
생-활성 지수(bioactivity index, BI)는 소비자가 유익한 특성에 기초하여 과일 또는 야채를 선택하는데 사용할 수 있다. 또한, 이는 전염병학 연구에 있어서 랭킹 데이터에 대한 도구로서 사용될 수 있다(Sun and others 2002). 최근의 연구에 의하면 BI는 다음의 방정식에 의해 결정되었다: BI = (총 항산화 활성 값 + 항증식 활성 값)/2, 여기에서 총 항산화활성 값 = 샘플 값/가장 높은 항산화 값, 항증식 활성 값 = 가장 높은 IC50 값/샘플 IC50 값.
The bioactivity index (BI) can be used by consumers to select fruits or vegetables based on beneficial properties. It can also be used as a tool for ranking data in epidemiological studies (Sun and others 2002). According to a recent study, BI was determined by the following equation: BI = (total antioxidant activity value + antiproliferative activity value) / 2, where total antioxidant activity value = sample value / highest antioxidant value, antiproliferative activity value = Highest IC 50 value / sample IC 50 value.
11. 통계적 분석 11. Statistical Analysis
모든 분석은 3회 반복 수행하였고 데이터는 평균 ㅁ SD 값으로 표현하였다. IC50 값은 용량-반응 곡선으로부터 계산하였고, 필요한 경우 다음의 공식을 사용하였다: Y = 100*A1/(X + A1), 여기에서 A1 = IC50, Y = 반응 및 X = 억제 농도(Y = 100%, X = 0인 경우). IC50 값은 paired Student's t-test에 의해 평가하였다. 시그마 플롯 소프트웨어 Version 9.0 (Jandel CoRPP., San Raphael, CA, USA)을 사용한 변수 회귀 분석에 의해 독립적인 변수간에 통계학적으로 유의한 관계가 확인되었다. p-값 < 0.05를 통계학적으로 의미있는 것으로 간주하였다. 폴리페놀 및 플라보노이드 함량과 세포 생존능 비율 사이의 관련성을 분석하기 위해 시그마 스태트 소프트웨어 Version 3.1 (Jandel CoRPP., San Raphael, CA, USA)을 사용하여 피어스 상관 분석(Pearson's correlation analysis)을 행하였다.
All analyzes were performed three times and data were expressed as mean W SD values. IC 50 values were calculated from dose-response curves and if necessary the following formula was used: Y = 100 * A1 / (X + A1), where A1 = IC 50 , Y = response and X = inhibitory concentration (Y = 100%, X = 0). IC 50 values were assessed by paired Student's t-test. Variable regression analysis using Sigma plot software Version 9.0 (Jandel CoRPP., San Raphael, Calif., USA) confirmed statistically significant relationships between independent variables. The p-value <0.05 was considered statistically significant. Pearson's correlation analysis was performed using Sigma State Software Version 3.1 (Jandel CoRPP., San Raphael, Calif., USA) to analyze the relationship between polyphenol and flavonoid content and cell viability ratio.
실험결과 Experiment result
1. 총 폴리페놀 및 플라보노이드 함량 1. Total Polyphenol and Flavonoid Content
적색 및 백색 피타야(pitaya)의 과육 및 껍질의 총 페놀 성분 함량은 Folin-Ciocalteu 방법에 따라 측정하였다(Wu and others 2006). 적색 피타야의 껍질 및 과육으로부터의 추출 가능한 총 페놀 성분의 함량은 각각 14.82±1.07 mg GAE/g 및 4.91±0.55 mg GAE/g 이었고, 적색 피타야의 경우는 각각 15.94±0.93 mg GAE/g 및 3.52±0.60 mg GAE/g 이었다. 표 1에는 상이한 피타야 추출물에서 폴리페놀 및 플라보노이드 함량과 %수율을 나타내었다. 표 1에서 나타난 바와 같이, 적색 피타야 껍질(red pitaya peel, RPP) 및 백색 피타야 껍질(white pitaya peel, WPP)의 메탄올 추출의 폴리페놀 함량은 적색 피타야 과육(red pitaya flesh, RPF) 및 백색 피타야 과육 (white pitaya flesh, WPF)의 것 보다 약 3-배 및 5-배 높았다. RPP는 플라보노이드 함량이 가장 높았고(18.16 ± 1.00 RE/g), 이어서, WPP (14.33 ± 0.58 RE/g), RPF (9.56 ± 0.11 RE/g), 및 WPF (3.52 ± 0.12 RE/g)순 이었다. The total phenolic content of the flesh and skin of red and white pitaya was measured according to the Folin-Ciocalteu method (Wu and others 2006). The total extractable phenolic content from the skin and pulp of red pitaya was 14.82 ± 1.07 mg GAE / g and 4.91 ± 0.55 mg GAE / g, respectively, and 15.94 ± 0.93 mg GAE / g and 3.52 ± 0.60 mg GAE / g. Table 1 shows the polyphenol and flavonoid contents and% yields in different pitaya extracts. As shown in Table 1, the polyphenol content of the methanol extraction of the red pitaya peel (RPP) and the white pitaya peel (WPP) is shown in the red pitaya flesh (RPF) and It was about 3- and 5-fold higher than that of the white pitaya flesh (WPF). RPP had the highest flavonoid content (18.16 ± 1.00 RE / g), followed by WPP (14.33 ± 0.58 RE / g), RPF (9.56 ± 0.11 RE / g), and WPF (3.52 ± 0.12 RE / g). .
상기 표 1에서 결과는 평균±표준편차로서 표현하였다. 대조군과 비교한 *P < 0.05이었다.
The results in Table 1 are expressed as mean ± standard deviation. * P <0.05 compared to control.
종합하여 설명하면, RPP 및 WPP는 폴리페놀과 플라보노이드의 함량은 비슷한 수준이었으며, 반면 RPF는 WPF에 비해 더욱 많은 양의 폴리페놀과 플라보노이드를 함유하고 있었다.
Taken together, RPP and WPP had similar levels of polyphenols and flavonoids, while RPF contained more polyphenols and flavonoids than WPF.
2. 자유 라디칼 소거 활성 2. Free radical scavenging activity
항산화 활성 평가의 통상적인 방법은 오직 하나의 특성에만 특이적이기 때문에 생물학적 물질의 항산화 활성을 평가하는 때에 주요한 이슈 중의 하나는 분석 방법의 선택이다. 많은 화학적 분석 방법은 특정 자유 라디칼, 예를 들어 수퍼옥사이드 음이온 또는 히드록실 또는 퍼옥시 라디칼에 의한 타겟 기질의 산화를 테스트되는 물질이 억제하는 능력을 측정한다(Hassimotto and others 2005). ESR은 반응성 종(species)을 민감하고, 직접적이며 정확하게 모니터링할 수 있는 것으로 알려져 있기 때문에(Guo and others 1999), 카테킨을 표준물질로 사용하여, 적색 및 백색 피타야 과육 및 껍질의 80% 메탄올 추출물의 DPPH, 히드록실 및 알킬 라디칼 소거능과 비교하는데 사용하였다.
Since conventional methods of antioxidant activity assessment are specific to only one property, one of the major issues when evaluating the antioxidant activity of biological materials is the choice of analytical method. Many chemical analysis methods measure the ability of a tested substance to inhibit the oxidation of a target substrate by certain free radicals such as superoxide anions or hydroxyl or peroxy radicals (Hassimotto and others 2005). Since ESR is known for sensitive, direct and accurate monitoring of reactive species (Guo and others 1999), 80% methanol extract of red and white pitaya pulp and bark using catechins as a standard It was used to compare DPPH, hydroxyl and alkyl radical scavenging ability of.
3. DPPH 라디칼 소거능 3. DPPH radical scavenging ability
DPPH는 프로톤 라디칼 소거제에 노출시키면 이의 수준이 크게 감소하는 안정한 자유 라디칼이다(Sanchez-Moreno 2002). 하기 표 2에서 보여지는 바와 같이, WPP의 80% 메탄올 추출물은 가장 높은 DPPH 라디칼 소거능을 나타내었고(68.12 ± 2.87%), 이어서, RPP (56.85 ± 5.65%), RPF (33.25 ± 1.84 %), 및 WPF (23.83 ± 3.33%)이었다. 여기서 모든 추출물들의 농도는 25 μg/㎖ 이었다. 예상된 바와 같이, 카테킨(catechin)은 우수한 항산화 활성(10 μg/㎖에서 83.76 ± 2.3)을 나타내었다. 추출물의 페놀성 함량과 DPPH 라디칼 소거 활성간에는 명확한 상관성이 존재하였다: 선형 상관계수, r2 = 0.949 (도 1). DPPH is a stable free radical whose level is greatly reduced upon exposure to proton radical scavengers (Sanchez-Moreno 2002). As shown in Table 2 below, the 80% methanol extract of WPP showed the highest DPPH radical scavenging activity (68.12 ± 2.87%), followed by RPP (56.85 ± 5.65%), RPF (33.25 ± 1.84%), and WPF (23.83 ± 3.33%). The concentration of all extracts here was 25 μg / ml. As expected, catechin showed good antioxidant activity (83.76 ± 2.3 at 10 μg / ml). There was a clear correlation between the phenolic content of the extract and the DPPH radical scavenging activity: linear correlation coefficient, r 2 = 0.949 (FIG. 1).
페놀 성분들은 과일에서 공통적으로 발견되고 항산화 활성을 나타내는 것으로 보고되고 있는데, 이는 이들의 페놀 부분의 반응성으로부터 유래한 것이며 수소 또는 전자 주기를 통해 자유 라디칼을 소거한다고 알려져 있다(Shahidi and Wanasundara 1992). DPPH 시스템에서 RPP와 비교하여 WPP의 보다 강한 항산화 활성은 WPP가 더 높은 수준의 폴리페놀 함량을 나타내는 것에 기인한다: 플라보노이드 함량에 대한 상관계수 (r2 = 0.785)는 폴리페놀의 것 보다 낮았다(도 1). 반면에 RPP는 WPP에 비해 높은 플라보노이드 함량을 나타내었다(표 1 참조). 따라서, WPP는 DPPH 자유 라디칼 소거제로서 더 유용할 것으로 보여진다.
Phenolic components are commonly found in fruits and have been reported to exhibit antioxidant activity, which is derived from the reactivity of their phenolic moieties and is known to eliminate free radicals via hydrogen or electron cycles (Shahidi and Wanasundara 1992). The stronger antioxidant activity of WPP compared to RPP in the DPPH system is due to the higher levels of polyphenol content of WPP: the correlation coefficient (r 2 = 0.785) for flavonoid content was lower than that of polyphenols (FIG. One). RPP, on the other hand, showed a higher flavonoid content compared to WPP (see Table 1). Thus, WPP appears to be more useful as a DPPH free radical scavenger.
4. 히드록실 라디칼 소거활성 4. hydroxyl radical scavenging activity
본 실험에서 Fe2+/H2O2 시스템내에서 생성된 히드록실 라디칼은 DMPO-형성 스핀 부가생성물에 의해 포집되었고, ESR 분광기(Saito and others 2008)를 사용하여 측정하였다. 식물로부터 유도된 페놀성 화합물들은 페놀성 화합물들의 산화 생성물은 알데히드 및 다이머들이다(Halliwel and Gutteridge 1999). 표 2에 나타낸 바와 같이, RPP, RPF, WPP 및 WPF 추출물의 소거 활성은 각각 64.45 ± 5.29%, 47.14 ± 4.47%, 62.12 ± 5.36%, 및 58.85 ± 3.82%이었다. 추출물의 농도는 모두 2 mg/mL 이었다. 카테킨(catechin)은 0.1 mg/mL의 농도에서 81.11 ± 1.8%의 히드록실 라디칼 소거 활성을 나타내었다. RPP 및 WPP 모두 다량의 폴리페놀과 플라보노이드를 함유하고 있으므로 수긍할 만한 활성을 나타내었다. 반면, WPF는 가장 적은 양의 폴리페놀과 플라보노이드를 함유하고 있음에도 불구하고 RPF보다 높은 활성을 보였다. 따라서, 폴리페놀 및 플라보노이드 함량과 히드록실 라디칼 소거 활성간에는 뚜렷한 상관관계가 확인되지는 않았다. 도 1에 보여지는 바와 같이, 폴리페놀 및 플라보노이드 함량과 히드록실 라디칼 소거 활성 간의 상관관계는 매우 약하였다: r2 = 0.496 및 r2 = 0.224. 이들의 높은 반응성 때문에 히드록실 라디칼은 비-장소-특이적 방법에서 산화적 방어를 부여하는 항산화 분자의 능력을 정확하게 반영하지 못 할 수도 있다(Adebajo and Gesser 2001). 그럼에도 불구하고 본 실험 결과는 적색 및 백색 피타야 과육 및 껍질 메탄올 추출물이 히드록실 라디칼에 대해 어떠한 방어를 제공할 수 있다는 것을 암시한다. The hydroxyl radicals generated in the Fe 2+ / H 2 O 2 system in this experiment were captured by DMPO-forming spin adducts and measured using an ESR spectrometer (Saito and others 2008). For phenolic compounds derived from plants, the oxidation product of phenolic compounds is aldehydes and dimers (Halliwel and Gutteridge 1999). As shown in Table 2, the scavenging activities of the RPP, RPF, WPP and WPF extracts were 64.45 ± 5.29%, 47.14 ± 4.47%, 62.12 ± 5.36%, and 58.85 ± 3.82%, respectively. The concentrations of the extracts were all 2 mg / mL. Catechin exhibited hydroxyl radical scavenging activity of 81.11 ± 1.8% at a concentration of 0.1 mg / mL. Since both RPP and WPP contained large amounts of polyphenols and flavonoids, they showed acceptable activity. WPF, on the other hand, showed higher activity than RPF despite containing the lowest amount of polyphenols and flavonoids. Thus, no clear correlation was found between polyphenol and flavonoid content and hydroxyl radical scavenging activity. As shown in FIG. 1, the correlation between polyphenol and flavonoid content and hydroxyl radical scavenging activity was very weak: r 2 = 0.496 and r 2 = 0.224. Because of their high reactivity, hydroxyl radicals may not accurately reflect the ability of antioxidant molecules to confer oxidative defenses in non-place-specific methods (Adebajo and Gesser 2001). Nevertheless, the results of this experiment suggest that red and white pitaya pulp and bark methanol extracts can provide some protection against hydroxyl radicals.
5. 알킬 라디칼 소거 활성 5. Alkyl radical scavenging activity
알킬 라디칼은 다양한 탄화수소 반응에서 주요한 중간체이고, ESR에 의해 쉽게 검출될 수 있다(Kim and others 2010). DPPH 라디칼 소거 활성과 유사하게, RPP 및 WPP 추출물은 RPF 및 WPF 추출물의 것(33.84 ± 4.61% 및 27.62 ± 5.60%)과 비교하여 약간 높은 정도의 라디칼 소거 활성을 나타내었다(49.98 ± 2.52% 및 42.36 ± 5.00%). 실험에 사용한 추출물들의 농도는 모두 200 μg/mL 이었다. 카테킨(catechin)은 12.5 μg/mL의 농도에서 강한 알킬 라디칼 소거능 (90.25 ± 3.1%)을 나타내었다(표 2 참조). 총 폴리페놀 및 플라보노이드 함량과 알킬 라디칼 소거 활성 사이의 상관 관계는 유의성이 매우 높은 수준이었다: r2 = 0.821 및 r2 = 0.977 (도 1). 상기 결과는 보편적이지는 않지만 플라보노이드도 매우 중요한 항산화성 페놀 화합물이라는 것을 암시한다. 페놀성 항산화제가 퍼옥시 라디칼을 포획하여 유기물질을 산화적 분해로부터 보호한다는 것이 공지되어 있으나, 자기 산화는 연쇄 담체로서 작용하는 퍼옥시 및 알킬 라디칼을 포함하고 있기 때문에 알킬 라디칼을 포집하여 산화적 분해로부터 보호하는 것 또한 중요하다(Nisizawa and others 1987). 소거능의 면에서, 적색 및 백색 피타야의 껍질(과육이 아닌)이 알킬 라디칼 소거능의 풍부한 원천으로서 가능성을 보여주었다.
Alkyl radicals are major intermediates in various hydrocarbon reactions and can be easily detected by ESR (Kim and others 2010). Similar to the DPPH radical scavenging activity, the RPP and WPP extracts exhibited a slightly higher degree of radical scavenging activity compared to that of the RPF and WPF extracts (33.84 ± 4.61% and 27.62 ± 5.60%) (49.98 ± 2.52% and 42.36 ± 5.00%). The concentrations of the extracts used in the experiment were all 200 μg / mL. Catechin showed strong alkyl radical scavenging activity (90.25 ± 3. 1%) at a concentration of 12.5 μg / mL (see Table 2). The correlation between total polyphenol and flavonoid content and alkyl radical scavenging activity was very significant: r 2 = 0.821 and r 2 = 0.977 (FIG. 1). The results suggest that, although not universal, flavonoids are also very important antioxidant phenolic compounds. Phenolic antioxidants are known to capture peroxy radicals to protect organics from oxidative degradation, but since self-oxidation involves peroxy and alkyl radicals that act as chain carriers, oxidative degradation can be achieved by trapping alkyl radicals. Protection from is also important (Nisizawa and others 1987). In terms of scavenging activity, the red (and not flesh) skins of red and white pitaya have shown potential as a rich source of alkyl radical scavenging activity.
6. 피타야 추출물의 암세포주의 생존능에 미치는 효과 6. Effect of Pitaya Extract on the Viability of Cancer Cell Lines
적색 및 백색 피타야의 과육 및 껍질 추출물의 3가지 종류의 암세포주, 인간 위암 세포주(AGS), 인간 자궁경부암 세포주(HeLa), 및 인간 유방암 세포주(MCF-7)에 대한 인 비트로 성장을 억제하는 효과에 대해서는 상기 표 2에 나타내었다. 각기 다른 피타야 추출물은 각기 다른 종류의 세포주에 대해 각기 다른 항증식 효과를 나타내었다. 이들 추출물은 다음과 같은 순위로 암세포주에 대해 생존 억제 효능을 나타내었다: WPP>RPP>RPF>WPF (표 2). 특히, 백색 및 적색 피타야의 껍질 추출물이 인간위암세포주 AGS와 유방암세포주 MCF-7에 대해 뛰어난 증식 억제 활성을 나타내었다. 항증식 활성이 폴리페놀 및 플라보노이드 함량과 상관관계가 있다는 것이 관찰되었다. 테스트된 추출물의 폴리페놀 및 플라보노이드 함량과 세포 생존능 비율을 측정하였다. Inhibits growth in vitro against three types of cancer cell lines, human gastric cancer cell line (AGS), human cervical cancer cell line (HeLa), and human breast cancer cell line (MCF-7) of red and white Pitaya pulp and bark extract The effects are shown in Table 2 above. Different pitaya extracts showed different antiproliferative effects on different cell lines. These extracts showed survival inhibitory effects against cancer cell lines in the following rankings: WPP> RPP> RPF> WPF (Table 2). In particular, the bark extract of white and red pitaya showed excellent proliferation inhibitory activity against human gastric cancer cell line AGS and breast cancer cell line MCF-7. It was observed that antiproliferative activity correlated with polyphenol and flavonoid content. Polyphenol and flavonoid content and cell viability ratio of the tested extracts were determined.
표 3은 추출물에 대해 행해진 모든 분석에 대한 Pearson's 상관 계수를 보여준다. Table 3 shows Pearson's correlation coefficients for all assays performed on the extracts.
a 는 p < 0.05에서 유의성 있는 값이고, b는 p < 0.01에서 유의성 있는 값을 의미한다. a is a significant value at p <0.05, b is a significant value at p <0.01.
HeLa, AGS, 및 MCF-7 암세포주의 세포 생존능 비율과 RPP, RPF, WPP, 및 WPF의 총 폴리페놀 함량과의 음성(negative) 상관관계 발견되었다 (r = -0.133 내지 -0.960). 이와 유사하게, 백색 및 적색 피타야 추출물의 플라보노이드 함량과 AGS, HeLa, 및 MCF-7 세포의 증식 사이의 음성(negative) 상관 계수가 발견되었다. 전체적으로, 테스트된 세포주에 관계없이 피타야의 껍질 추출물이 과육 추출물에 비해 높은 암세포 항증식 활성을 나타내었다. 이들 결과들은 피타야 추출물들의 암세포주에 대해 항-증식 효과가 이들이 함유하고 있는 폴리페놀 및 플라보노이드의 조합된 효과로부터 유래된 것일 수 있다는 것을 암시한다.
A negative correlation was found between the percentage of cell viability of HeLa, AGS, and MCF-7 cancer cell lines and the total polyphenol content of RPP, RPF, WPP, and WPF (r = −0.133 to −0.960). Similarly, a negative correlation coefficient was found between the flavonoid content of the white and red pitaya extract and the proliferation of AGS, HeLa, and MCF-7 cells. Overall, regardless of the cell lines tested, Pitaya's bark extract showed higher cancer cell antiproliferative activity than the pulp extract. These results suggest that the anti-proliferative effect on pitaya extracts on cancer cell lines may be derived from the combined effects of the polyphenols and flavonoids they contain.
7. 항산화 활성 및 항증식 효과 사이의 상관관계 7. Correlation Between Antioxidant Activity and Antiproliferative Effect
본 발명의 실험결과 고함량의 폴리페놀과 DPPH 라디칼 소거 활성을 갖는 WPP 추출물이 암세포주에 대해 가장 강력한 항증식 효과를 나타낸다는 것을 확인하였다. 그러나, 항산화 활성과 항증식 영향 사이에는 직접적인 상관관계는 없었다. 상이한 피타야 추출물의 암세포에 대한 항증식 활성은 항산화 활성과 뚜렷한 상관관계를 보여주지는 못하였다(도 2). DPPH 라디칼 소거활성은 HeLa 세포 성장 IC50에 대해 가장 강력한 상관관계를 보여주었다(r2 = .0965). 피타야 추출물에 의한 암세포 증식의 억제는 이들의 폴리페놀 함량만으로는 설명될 수 없다. 이는 특정 페놀 화합물이 추출물의 항증식 활성에 개별적으로 기여하는 것이 아니며, 대신 폴리페놀 및 플라보노이드 및/또는 추출물에 존재하는 다른 피토케미칼(phytochemical) 조합의 상승적 작용으로부터 얻어지는 결과일 수 있다는 것을 암시한다. 또한, 상기 결과는 테스트된 피타야 추출물에 존재하는 폴리페놀이 중요한 항산화 역할을 수행한다는 것을 암시한다.
Experimental results of the present invention confirmed that the WPP extract having a high content of polyphenols and DPPH radical scavenging activity shows the strongest antiproliferative effect against cancer cell lines. However, there was no direct correlation between antioxidant activity and antiproliferative effects. Antiproliferative activity against cancer cells of different pitaya extracts did not show a clear correlation with antioxidant activity (FIG. 2). DPPH radical scavenging activity showed the strongest correlation for HeLa cell growth IC 50 (r 2 = .0965). Inhibition of cancer cell proliferation by pitaya extract cannot be explained by their polyphenol content alone. This suggests that certain phenolic compounds do not contribute individually to the antiproliferative activity of the extract but may instead result from the synergistic action of polyphenols and flavonoids and / or other phytochemical combinations present in the extract. The results also suggest that the polyphenols present in the tested pitaya extract play an important antioxidant role.
8. 생-활성 지수의 중요성 8. Importance of Bioactivity Index
수요자의 과일 구매시에 어떤 과일을 선택할지에 대해 간단한 참조를 제공할 수 있는 BI(생-활성 지수, bioactivity index)를 제공한다. WPP는 DPPH 라디칼의 가장 강력한 소거자이고 대부분의 테스트된 암세포주의 성장 억제자이기 때문에, 다른 추출물들의 BI 값의 산출에 대한 상대적인 참조로써 사용되었다. 표 2에 나타난 바와 같이, 백색 피타야의 껍질 및 과육 추출물은 대응하는 적색 피타야 추출물에 비해 더 높은 BI 값을 가졌다. 총 항산화 활성 또는 항증식 활성 자체와 비교하여 BI는 추출물 활성 판단에서 더 유용한 값이다.
It provides a bioactivity index (BI) that can provide a brief reference on which fruit to choose when buying a consumer's fruit. Since WPP is the most potent scavenger of DPPH radicals and the growth inhibitor of most tested cancer cell lines, it was used as a relative reference to the calculation of BI values of other extracts. As shown in Table 2, the skin and pulp extracts of the white pitaya had higher BI values compared to the corresponding red pitaya extract. Compared to total antioxidant activity or antiproliferative activity itself, BI is a more useful value in determining extract activity.
9. 결론 9. Conclusion
결론적으로, 본 발명자들은 적색 및 백색 피타야 과육 및 껍질의 폴리페놀 및 플라보노이드 함량에 있어서 상당한 차이가 있다는 것을 증명하였고, 백색 피타야의 껍질에 다양한 항산화 및 항증식 물질들이 풍부하게 존재한다는 것을 실험적으로 확인하였다. 또한, 피타야 추출물들은 암세포주의 항-증식 효과를 나타내어, 암과 같은 만성질환의 예방 및 치료를 돕는 매우 가치 있는 물질임을 증명하였다.
In conclusion, the present inventors have demonstrated that there are significant differences in the polyphenol and flavonoid content of red and white phytaya pulp and bark, and experimentally that the abundance of various antioxidant and antiproliferative substances are present in the bark of white pitaya. Confirmed. In addition, phytaya extracts have anti-proliferative effects in cancer cell lines, proving that they are very valuable substances that help prevent and treat chronic diseases such as cancer.
이상으로 본 발명의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현 예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다.
While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the same is by way of illustration and example only and is not to be construed as limiting the scope of the present invention. Thus, the substantial scope of the present invention will be defined by the appended claims and equivalents thereof.
참조문헌 References
Adebajo MO, Gesser HD. 2001. ESR study of alkyl radicals adsorbed on porous Vycor glass. I. Build up of mehyl and ethyl radicals. App SuRPF Sci 171:120-4.Adebajo MO, Gesser HD. 2001. ESR study of alkyl radicals adsorbed on porous Vycor glass. I. Build up of mehyl and ethyl radicals. App SuRPF Sci 171: 120-4.
Alothman M, Bhat R, Karim AA. 2009. Antioxidant capacity and phenolic content of selected tropical fruits form Malaysia, extracted with different solvents. Food chem 115:785-98.Alothman M, Bhat R, Karim AA. 2009. Antioxidant capacity and phenolic content of selected tropical fruits form Malaysia, extracted with different solvents. Food chem 115: 785-98.
Asmah R, Laili MN, Fadzelly ABM. 2008. Free radical scavenging activity of two Hylocereus species (Cactaceae) and their effect on the proliferation of HeLa and MDA-MB-231 cancer cell lines. Proceedings of the 7th Joint Meeting of GA, AFERPP, ASP, PSE & SIF, Planta medica 74: PA 5.Asmah R, Laili MN, Fadzelly ABM. 2008.Free radical scavenging activity of two Hylocereus species (Cactaceae) and their effect on the proliferation of HeLa and MDA-MB-231 cancer cell lines. Proceedings of the 7th Joint Meeting of GA, AFERPP, ASP, PSE & SIF, Planta medica 74: PA 5.
Chen X, He B. 2007. Oxygen free radical scavenging activity and anti-lipid peroxidation of tea polyphenol. Zhong Yao Cai 21:141-5Chen X, He B. 2007. Oxygen free radical scavenging activity and anti-lipid peroxidation of tea polyphenol. Zhong Yao Cai 21: 141-5
Cheung LM, Cheung PC, Ooi VE. 2003. Antioxidant activity and total phenolics of edible mushroom extracts. Food Chem 81:249-55.Cheung LM, Cheung PC, Ooi VE. 2003. Antioxidant activity and total phenolics of edible mushroom extracts. Food Chem 81: 249-55.
Chidambara-Murthy KN, Singh RPP, Jayaprakasha GK. 2002. Antioxidant activities of grape Vitis vinifera pomace extracts. J Agri Food Chem 50:5909-14. Chidambara-Murthy KN, Singh RPP, Jayaprakasha GK. 2002.Antioxidant activities of grape Vitis vinifera pomace extracts. J Agri Food Chem 50: 5909-14.
Chu Y, Sun J, Wu X, Liu RH. 2002. Antioxidant and antiproliferative activity of common vegetables. J Agric Food Chem 50:6910-16. Chu Y, Sun J, Wu X, Liu RH. 2002. Antioxidant and antiproliferative activity of common vegetables. J Agric Food Chem 50: 6910-16.
Cos P, Bruyne DT, Hermans N, Apers S, Berghe DV, Vlietinck AJ. 2004. Proanthocyanidins in health care: current and new trends. Curr Medi Chem 11:1345-59.Cos P, Bruyne DT, Hermans N, Apers S, Berghe DV, Vlietinck AJ. 2004. Proanthocyanidins in health care: current and new trends. Curr Medi Chem 11: 1345-59.
Das, UN. 2000. Beneficial effects of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostag Leukotr Ess 63:351-2.Das, UN. 2000. Beneficial effects of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostag Leukotr Ess 63: 351-2.
Guo Q, Zhao B, Shen S, Hou J, Hu J, Xin W. 1999. ESR study on the structure antioxidant activity relationship of tea catechins and their epimers. Biochim Biophys Acta 1427:13-23.Guo Q, Zhao B, Shen S, Hou J, Hu J, Xin W. 1999. ESR study on the structure antioxidant activity relationship of tea catechins and their epimers. Biochim Biophys Acta 1427: 13-23.
Halliwel B, Gutteridge JMC. 1999. Chemistry of biologically important radicals, In: Free Radicals in Biology and Medicine (3rd edn). New York: Oxford University Press. p 48-82.Halliwel B, Gutteridge JMC. 1999. Chemistry of biologically important radicals, In: Free Radicals in Biology and Medicine (3rd edn). New York: Oxford University Press. p 48-82.
Hansen MB, Nielsen SE, Berg K. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Imm Meth 119:203-10.Hansen MB, Nielsen SE, Berg K. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth / cell kill. J Imm Meth 119: 203-10.
Hassimotto NMA, Genovese MI, Lajolo FM. 2005. Antioxidant activity of dietary fruits, vegetables, and Commercial frozen fruit pulps. J Agri Food chem 53:2928-35.Hassimotto NMA, Genovese MI, Lajolo FM. 2005. Antioxidant activity of dietary fruits, vegetables, and Commercial frozen fruit pulps. J Agri Food chem 53: 2928-35.
Hiramoto K, Johkoh H, Sako K, Kikugawa K. 1993. DNA breaking activity of the carbon-centered radical generated from 2,2'-azobis(2-amidinopropane) hydrochloride (AAPH). Free Radi Res Comm 19:323-32.Hiramoto K, Johkoh H, Sako K, Kikugawa K. 1993. DNA breaking activity of the carbon-centered radical generated from 2,2'-azobis (2-amidinopropane) hydrochloride (AAPH). Free Radi Res Comm 19: 323-32.
Hoa TT, Clark CJ, Waddell BC, Woolf AB. 2006. Postharvest quality of Dragon fruit (Hylocereus undatus) following disinfesting hot air treatments. Postharvest Bio Tech 41:62-9.Hoa TT, Clark CJ, Waddell BC, Woolf AB. 2006. Postharvest quality of Dragon fruit (Hylocereus undatus) following disinfesting hot air treatments. Postharvest Bio Tech 41: 62-9.
Huang X, Dai J, Fournier J, Ali AM, Zhang Q, Frenkel K. 2002. Ferrous ion autoxidation and its chelation in iron-loaded human liver Hep G2 cells. Free Radi Bio Med 32:84-72.Huang X, Dai J, Fournier J, Ali AM, Zhang Q, Frenkel K. 2002. Ferrous ion autoxidation and its chelation in iron-loaded human liver Hep G2 cells. Free Radi Bio Med 32: 84-72.
Kim H, Moon JY, Kim HJ, Lee DH, Cho M, Choi HK, Kim YS, Mosaddik MA, Cho SK. 2010;. Antioxidant and antiproliferative activities of mango (Mangifera indica L.) flesh and peel. Food Chem 121: 429-36.Kim H, Moon JY, Kim HJ, Lee DH, Cho M, Choi HK, Kim YS, Mosaddik MA, Cho SK. 2010 ;. Antioxidant and antiproliferative activities of mango (Mangifera indica L.) flesh and peel. Food Chem 121: 429-36.
Li SF, Liu XM, Wu JJ, Chen ZY, Shu N, Zhu ZW. 2003. The development of pitaya. Sci Tech Food Indus 7:88-90.Li SF, Liu XM, Wu JJ, Chen ZY, Shu N, Zhu ZW. 2003. The development of pitaya. Sci Tech Food Indus 7: 88-90.
Liu M, Li XQ, Weber C, Lee CY, Brown J, Liu RH. 2002. Antioxidant and antiproliferative activities of raspberries. J Agri Food Chem 50:2926-30.Liu M, Li XQ, Weber C, Lee CY, Brown J, Liu RH. 2002. Antioxidant and antiproliferative activities of raspberries. J Agri Food Chem 50: 2926-30.
Mahattanatawee K, Manthey JA, Luzio G, Talcott ST, Goodner K, Baldwin EA. 2006. Total antioxidant activity and content of select Florida-Grown tropical fruits. J Agri Food Chem 54:7355-63.Mahattanatawee K, Manthey JA, Luzio G, Talcott ST, Goodner K, Baldwin EA. 2006. Total antioxidant activity and content of select Florida-Grown tropical fruits. J Agri Food Chem 54: 7355-63.
Menon LG, Kuttan R, Kuttan G. 1995. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Can lett 95:221-5.Menon LG, Kuttan R, Kuttan G. 1995. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Can lett 95: 221-5.
Meyers KJ, Watkins CB, Pritts MP, Lui RH. 2003. Antioxidant and antiproliferative activities of strawberries. J Agri Food Chem 51:6887-92. Meyers KJ, Watkins CB, Pritts MP, Lui RH. 2003. Antioxidant and antiproliferative activities of strawberries. J Agri Food Chem 51: 6887-92.
Mizrahi Y, Nerd A, Nobel PS. 1997. Cacti as Crops. Horti revie 18:291-320.Mizrahi Y, Nerd A, Nobel PS. 1997. Cacti as Crops. Horti revie 18: 291-320.
Mokbel MS, Hashinaga F. 2006. Evaluation of the antioxidant activity of extracts from buntan (Citrus grandis Osbeck) fruit tissues. Food Chem 94:529-34.Mokbel MS, Hashinaga F. 2006. Evaluation of the antioxidant activity of extracts from buntan (Citrus grandis Osbeck) fruit tissues. Food Chem 94: 529-34.
Nanjo F, Goto K, Seto R, Suzuki M, Sakai M, Hara Y. 1996. Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. Free Radi Bio Med 21:895-902.Nanjo F, Goto K, Seto R, Suzuki M, Sakai M, Hara Y. 1996. Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. Free Radi Bio Med 21: 895-902.
Nerd A, Sitrita Y, Kaushika RA, Mizrahi Y. 2002. High summer temperatures inhibit flowering in vine pitaya crops (Hylocereus spp). Scientia Horticulturae 96:343-50.Nerd A, Sitrita Y, Kaushika RA, Mizrahi Y. 2002. High summer temperatures inhibit flowering in vine pitaya crops (Hylocereus spp). Scientia Horticulturae 96: 343-50.
Nisizawa K, Noda H, Kikuchi R, Watamaba T. 1987. The main seaweed foods in Japan. Hydrobiologia 151/152:5-29.Nisizawa K, Noda H, Kikuchi R, Watamaba T. 1987. The main seaweed foods in Japan. Hydrobiologia 151/152: 5-29.
Rosen GM, Rauckman EJ. 1984. Spin trapping of superoxide and hydroxyl radicals. Meth in Enzymo 105:198-209.Rosen GM, Rauckman EJ. 1984. Spin trapping of superoxide and hydroxyl radicals. Meth in Enzymo 105: 198-209.
Saito K, Kohno M, Yoshizaki F, Niwano Y. 2008. Antioxidant properties of herbal extracts selected from screening for potent scavenging activity against superoxide anions. J Sci Food Agri 88:2707-12.Saito K, Kohno M, Yoshizaki F, Niwano Y. 2008. Antioxidant properties of herbal extracts selected from screening for potent scavenging activity against superoxide anions. J Sci Food Agri 88: 2707-12.
Sanchez-Moreno. 2002. Methods used to evaluate the free radical scavenging activity in foods and biological systems. Food Sci Tech Int 8:121-37.Sanchez-Moreno. 2002. Methods used to evaluate the free radical scavenging activity in foods and biological systems. Food Sci Tech Int 8: 121-37.
Shahidi F, Wanasundara PK. 1992. Phenolic antioxidants. Crit Rev Food Sci Nutri 32:67-103.Shahidi F, Wanasundara PK. 1992. Phenolic antioxidants. Crit Rev Food Sci Nutri 32: 67-103.
Shahidi F. 1997. Natural antioxidants: An overview, In: Shahidi F (ed), Natural antioxidants, chemistry, health effects and applications. IL: Champaign, AOCS press. p 1-11.Shahidi F. 1997. Natural antioxidants: An overview, In: Shahidi F (ed), Natural antioxidants, chemistry, health effects and applications. IL: Champaign, AOCS press. p 1-11.
Singh U, Kunwar A, Srinivasan R, Nanjan MJ, Priyadarsini KI. 2009. Differential free scavenging activity and radioprotection of Caesalpinia digyna extracts and its active constituent. J Radiat Res 50:425-33.Singh U, Kunwar A, Srinivasan R, Nanjan MJ, Priyadarsini KI. 2009. Differential free scavenging activity and radioprotection of Caesalpinia digyna extracts and its active constituent. J Radiat Res 50: 425-33.
Soo-Jin H, Kim JP, Jung WK, Lee NH, Kang HS, Jun EM, Park SH, Kang SM, Lee YJ, Park PJ, Jeon YJ. 2008. Identification of chemical structure and free radical scavenging activity of diphlorethohydroxycarmalol isolated form a brown alga, Ishige okamurae. J Micro Biotech 18:676-81. Soo-Jin H, Kim JP, Jung WK, Lee NH, Kang HS, Jun EM, Park SH, Kang SM, Lee YJ, Park PJ, Jeon YJ. 2008. Identification of chemical structure and free radical scavenging activity of diphlorethohydroxycarmalol isolated form a brown alga, Ishige okamurae. J Micro Biotech 18: 676-81.
Stintzing FC, Conrad J, Klaiber I, Beifuss U, Carle R. 2004. Structural investigations on betacyanin pigments by LC NMR and 2D NMR spectroscopy. Phytochemistry 65:415-22. Stintzing FC, Conrad J, Klaiber I, Beifuss U, Carle R. 2004. Structural investigations on betacyanin pigments by LC NMR and 2D NMR spectroscopy. Phytochemistry 65: 415-22.
Stintzing FC, Schieber A, Carle R. 2002. Betacyanins in fruits from red-purple pitaya, Hylocereus polyrhizus (Weber) Britton & Rose. Food Chem 77:101-6.Stintzing FC, Schieber A, Carle R. 2002. Betacyanins in fruits from red-purple pitaya, Hylocereus polyrhizus (Weber) Britton & Rose. Food Chem 77: 101-6.
Sun J, Chu Y, Wu X, Liu R. 2002. Antioxidant and antiproliferative activities of common fruits. J Agri Food Chem 50:7449-54.Sun J, Chu Y, Wu X, Liu R. 2002. Antioxidant and antiproliferative activities of common fruits. J Agri Food Chem 50: 7449-54.
Szentmihㅱlyi K, Vinkler P, Lakatos B, Illㅹs V, Then M. 2002. Rose hip (Rosa canina L.) oil obtained from waste hip seeds by different extraction methods. Bioresou Tech 82:195-201.Szentmihlyi K, Vinkler P, Lakatos B, Ill's V, Then M. 2002. Rose hip (Rosa canina L.) oil obtained from waste hip seeds by different extraction methods. Bioresou Tech 82: 195-201.
Tachakittirungrod S, Olonogi S, Chowwanapoonpohn S. 2007. Study on antioxidant activity of certain plants in Thailand: Mechanism of antioxidant action of guava leaf extract, Food Chem 103:381-88. Tachakittirungrod S, Olonogi S, Chowwanapoonpohn S. 2007. Study on antioxidant activity of certain plants in Thailand: Mechanism of antioxidant action of guava leaf extract, Food Chem 103: 381-88.
Wolfe K, We X, Liu RH. 2003. Antioxidant activity of apple peels. J Agri Food Chem 51:609-4. Wolfe K, We X, Liu RH. 2003. Antioxidant activity of apple peels. J Agri Food Chem 51: 609-4.
Wu L, Hsu HW, Chen YC, Chiu CC, Lin YI, Ho JA. 2006. Antioxidant and antiproliferative activities of red pitaya. Food Chem 95:319-27.Wu L, Hsu HW, Chen YC, Chiu CC, Lin YI, Ho JA. 2006.Antioxidant and antiproliferative activities of red pitaya. Food Chem 95: 319-27.
Wybranice S, Mizrahi Y. 2002. Fruit flesh betacyanin pigments in hyloceruus Cacti. J Agri Food Chem 50:6086-89. Wybranice S, Mizrahi Y. 2002. Fruit flesh betacyanin pigments in hyloceruus Cacti. J Agri Food Chem 50: 6086-89.
Zhishen J, Mengcheng T, Jianming W. 1999. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem 64:555-69.
Zhishen J, Mengcheng T, Jianming W. 1999. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem 64: 555-69.
Claims (5)
Anticancer composition comprising a white pitaya ( Hylocereus undatus ) extract as an active ingredient.
The composition of claim 1, wherein the white pitaya extract is a bark or pulp extract.
The composition of claim 1, wherein the pitaya extract is a solvent extract of water, anhydrous or hydrous lower alcohol having 1 to 4 carbon atoms, acetone, ethyl acetate, butyl acetate or 1,3-butylene glycol.
The composition of claim 1, wherein the composition is in the form of a pharmaceutical composition for the treatment or prevention of cancer.
The composition of claim 1, wherein the composition is in the form of a functional food composition for alleviating or ameliorating cancer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100069185A KR101230918B1 (en) | 2010-07-16 | 2010-07-16 | Anti-Cancer Composition Comprising Extract from Hylocereus undatus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100069185A KR101230918B1 (en) | 2010-07-16 | 2010-07-16 | Anti-Cancer Composition Comprising Extract from Hylocereus undatus |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120008370A true KR20120008370A (en) | 2012-01-30 |
KR101230918B1 KR101230918B1 (en) | 2013-02-07 |
Family
ID=45613392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100069185A KR101230918B1 (en) | 2010-07-16 | 2010-07-16 | Anti-Cancer Composition Comprising Extract from Hylocereus undatus |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101230918B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102013100596A1 (en) | 2012-01-27 | 2013-08-01 | Samsung Electronics Co. Ltd. | Method for performing overwriting operation in e.g. vertical NOT-AND (NAND) flash memory device used in e.g. mobile telephone, involves providing memory cell with different program modes, if respective-bit-data is stored |
-
2010
- 2010-07-16 KR KR1020100069185A patent/KR101230918B1/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102013100596A1 (en) | 2012-01-27 | 2013-08-01 | Samsung Electronics Co. Ltd. | Method for performing overwriting operation in e.g. vertical NOT-AND (NAND) flash memory device used in e.g. mobile telephone, involves providing memory cell with different program modes, if respective-bit-data is stored |
Also Published As
Publication number | Publication date |
---|---|
KR101230918B1 (en) | 2013-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chen et al. | Antioxidant activities and contents of free, esterified and insoluble-bound phenolics in 14 subtropical fruit leaves collected from the south of China | |
Nabavi et al. | Antioxidant activity of flower, stem and leaf extracts of Ferula gummosa Boiss | |
Kim et al. | Antioxidant and antiproliferative activities of mango (Mangifera indica L.) flesh and peel | |
Airaodion et al. | Comparative assessment of phytochemical content and antioxidant potential of Azadirachta indica and Parquetina nigrescens leaves | |
Ebrahimzadeh et al. | Antioxidant and free radical scavenging activity of H. officinalis L. var. angustifolius, V. odorata, B. hyrcana and C. speciosum | |
Shah et al. | Antioxidant potential, DNA protection, and HPLC-DAD analysis of neglected medicinal Jurinea dolomiaea roots | |
Nabavi et al. | The antioxidant activity of wild medlar (Mespilus germanica L.) fruit, stem bark and leaf | |
Miceli et al. | Phenolic composition and biological activities of Juniperus drupacea Labill. berries from Turkey | |
Megala et al. | Free radical-scavenging and H+, K+-ATPase inhibition activities of Pithecellobium dulce | |
Serteser et al. | Antioxidant properties of some plants growing wild in Turkey | |
Dhaouadi et al. | Commercial Lawsonia inermis L. dried leaves and processed powder: Phytochemical composition, antioxidant, antibacterial, and allelopathic activities | |
Zendehbad et al. | Flavonoids and phenolic content in wheat grass plant (Triticum aestivum) | |
Rakholiya et al. | Comparative analysis and simultaneous quantification of antioxidant capacity of four terminalia species using various photometric assays | |
Chew et al. | Evaluation and comparison of antioxidant activity of leaves, pericarps and pulps of three Garcinia species in Malaysia | |
Sabtain et al. | A narrative review on the phytochemistry, nutritional profile and properties of prickly pear fruit | |
Forouzani et al. | Evaluation of three methods for the extraction of antioxidants from Cucumis melo L. fruit and leaves | |
Veskoukis et al. | Grape stem extracts from three native Greek vine varieties exhibit strong antioxidant and antimutagenic properties | |
Gacche et al. | Antioxidant potential of selected vegetables commonly used in diet in Asian subcontinent | |
Khalid et al. | Free radical scavenging and total phenolic content of Saccharum spontaneum L. root extracts | |
D'Angelo et al. | Protective effect of polyphenols from Glycyrrhiza glabra against oxidative stress in Caco-2 cells | |
Terzić et al. | Could elderberry fruits processed by modern and conventional drying and extraction technology be considered a valuable source of health-promoting compounds? | |
Hemali et al. | Evaluation of antioxidant efficacy of different fractions of Tagetes erecta L. Flowers | |
Ayşe et al. | Medical and cosmetic applications of persimmon (Diospyros Kaki): Toxicity assessment-A review | |
Deshpande et al. | In-vitro antioxidant activity of different fraction of roots of Cassia auriculata Linn. | |
KR101230918B1 (en) | Anti-Cancer Composition Comprising Extract from Hylocereus undatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20160119 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20170103 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20171227 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20190613 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20191204 Year of fee payment: 8 |